SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform
SPHERE HEALTH opened early access to its virtual care platform for women with hormonal and metabolic conditions, the company said in a press release. The service covers conditions and stages including polyendocrine metabolic ovarian syndrome, endometriosis, perimenopause and menopause.
Its Rosalyn platform uses AI to combine a patient's assessment, medical history and laboratory results into one view. It prepares information for review by board certified physicians, who approve care plans and make treatment decisions. Clinical care is provided by independent licensed physicians.
The service offers a $99 one time laboratory and physician review option, a $149 monthly plan and a $349 monthly plan with expanded testing and a care navigator. Medication costs are separate. Early access starts through the company's waitlist and is not available in Hawaii or Rhode Island.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 21 Chelsea and Westminster Hospital launches multilingual AI avatar platform for lung cancer patients Nov 21 ChatGPT Health reaches Android, desktop and dots; health chats now follow the training setting Nov 20 OpenAI launches MedChemBench to test AI models on medicinal chemistry reasoning Nov 20 Danaher and Microsoft build an agentic platform for lab instruments Nov 19 Knit Health raises $35 million to roll out its healthcare world modelLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Hone Health raises $228 million to expand AI-enabled longevity care
Unio Health Partners deploys Basata's AI agents for patient intake across 60 specialty clinics
Siggy Raises $6 Million for AI Mental Health Service
Pathos AI Raises $237 Million at $3 Billion Valuation
Chris Hemsworth co-founds KINSYN, a wellness platform that uses AI on medical and wearable data
Daily AI Brief: the AI news that matters, in your inbox.